Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain

NCT06897917 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

203

Enrollment

OTHER_GOV

Sponsor class

Conditions

Opioid-Induced Constipation
Pain Cancer

Interventions

DRUG: Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets

Sponsor

Henan Cancer Hospital